Search results
AbbVie lifts profit forecast after Skyrizi sales beat expectations
Reuters· 4 days ago, opens new tab raised its annual profit forecast on Friday after strong sales of its immunology drug Skyrizi and cancer drug Imbruvica helped the company beat Wall Street estimates for the ...
AbbVie Stock Falls As Company Warns of Continued Humira Sales Slump
Investopedia· 4 days agoShares of AbbVie (ABBV) slumped Friday as the pharmaceutical firm warned of deeper declines in sales...
AbbVie: Q1 Earnings Snapshot
Houston Chronicle· 4 days agoOn a per-share basis, the North Chicago, Illinois-based company said it had net income of 77 cents. The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed ...
AbbVie hikes 2024 earnings guidance as Q1 beat estimates, shares up
Investing.com· 4 days agoAbbVie hikes 2024 earnings guidance as Q1 beat estimates, shares up
Gear Up for AbbVie (ABBV) Q1 Earnings: Wall Street Estimates for Key Metrics
Zacks via Yahoo Finance· 7 days agoGet a deeper insight into the potential performance of AbbVie (ABBV) for the quarter ended March...
AbbVie hikes 2024 earnings guidance as Q1 beat estimates, shares up By Investing.com
Investing.com· 4 days agoAbbVie hikes 2024 earnings guidance as Q1 beat estimates, shares up
Coming to a CVS Near You: A Store Brand Monoclonal Antibody
The Wall Street Journal· 21 hours agoIt came just as Humira, the highest-grossing drug of all time, was set to start facing competition...
3 Dividend Stocks to Buy and Hold for the Next Decade
Motley Fool via Yahoo Finance· 3 days agoYou only have to find the right stocks worthy of holding for the long term and that pay attractive...
AbbVie Inc (ABBV) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations with ...
GuruFocus.com via Yahoo Finance· 3 days agoAnd could you give us some confidence that you can continue to grow in '25 despite these headwinds from IRA and Humira? A: Robert A. Michael - AbbVie Inc. - President & COO ...
AbbVie raises earnings forecast on strong immunology drug growth
Crain s Chicago Business· 4 days agoThe growth helped offset sales declines of Humira, AbbVie’s once best-selling immunosuppressive medication that began facing biosimilar competition last year. Humira sales ...